THERAPEUTIC AREA PORTFOLIO · 37 PRODUCTS
Metabolic & Endocrine
代谢与内分泌
Driven by the catalog’s GLP-1, incretin, SGLT2 and DPP-4 programs, this area brings together intermediates for established diabetes therapies and emerging oral or peptide-based approaches to obesity and metabolic disease.
Target APIs & Active Pipeline Programs in Metabolic & Endocrine
SemaglutideEmpagliflozinLiraglutideSitagliptinOmarigliptinCagrilintideCanagliflozinDapagliflozinDanuglipronMazdutideOrforglipronRetatrutideSurvodutideTirzepatideVildagliptinAlogliptinLinagliptinAleniglipron
Metabolic & Endocrine Products (37)
Catalog products related to terminal APIs in this area.
B-02CAS 2212021-51-5
1-((1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl)-5-(tetrahydro-2H-pyran-4-yl)-1Hindole-2-carboxylic acidTarget API: Aleniglipron
B-06CAS 32384-65-9
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactoneTarget API: Canagliflozin/Dapagliflozin
B-08CAS 915095-94-2
(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furanTarget API: Empagliflozin
B-22CAS 1118767-16-0
(S)-22-(Tert-butoxycarbonyl)-10,19,24-trioxo-3,6,12,15-tetraoxa-9,18,23-triazahentetracontane-1,41-dioic acidTarget API: Semaglutide
B-23CAS 560088-89-3
10-Oxo-5,8,14,17-tetraoxa-2,11-diazanonadecanedioic acid 1-(9H-fluoren-9-ylmethyl) esterTarget API: Semaglutide
B-28CAS 762240-92-6
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a] pyrazine hydrochlorideTarget API: Sitagliptin
B-35CAS 2212021-83-3
5-((S)-2,2-dimethyltetrahydro2H-pyran-4-yl)-1-((1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro1,2,4-oxadiazol-3-yl) cyclopropyl)-1H-indole-2- carboxylic acidTarget API: Omarigliptin
B-36CAS 2212021-59-3
5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 3-amino-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl ester, (4S)-Target API: Omarigliptin
B-37CAS 2212021-61-7
tert-Butyl (S)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-3-(2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylateTarget API: Omarigliptin
